3891 results for «2023»

Filter By

3891 results

Recent clinical evidence for mitral TEER the CLASP IID trial

06 Dec 2023 – From PCR London Valves 2023

What is the CLASP IID registry and what are the key learnings from 1-year data? Philipp Lurz and Jörg Hausleiter describe the methodology of the programme which compares Pascal vs Mitraclip in patients with degenerative mitral regurgitation. Discover the key findings which are relevant to your practice.

This...

Recent clinical evidence for mitral TEER the CLASP IID trial

Empowering European Healthcare Systems: RESIL-Card, an EU4Health Project, Launches to Enhance Cardiovascular Care Resilience

19 Jan 2024

Paris, 18 January 2024: The consortium and supporting partners that make up the RESIL-Card project kick-started the venture on 1st December 2023.
The 3-year project received a funding grant from the European Commission under the EU4Health Work Programme to strengthen European healthcare systems in providing continuity of care for...

RESIL-Card_Image_project concept

Latest on TAVI in complex bicuspid lesions

17 May 2023 – From EuroPCR 2023

The bicuspid aortic valve is a real challenge in terms of diagnosis and treatment of patients, as discussed by Didier Tchétché and Raj Makkar in this interview.

Given that there are different phenotypes and patterns of calcification, some patients should indeed not be treated by TAVI: find out...

Latest on TAVI in complex bicuspid lesions

Should we perform revascularisation in patients with depressed left ventricle ejection fraction?

17 May 2023 – From EuroPCR 2023

Divaka Perera, main author of the REVIVED study, discusses the results of this trial with Flavio Ribichini.

REVIVE was a trial of severe ischaemic cardiomyopathy in which the primary outcome was death or heart failure hospitalization.The headline result was that there was absolutely no difference with PCI,...

Should we perform revascularisation in patients with depressed left ventricle ejection fraction?

Implications of TRILUMINATE, a randomized clinical trial of transcatheter repair for tricuspid regurgitation

17 May 2023 – From EuroPCR 2023

Listen to Nicole Karam and Fabien Praz talk about the latest update from the TRILUMINATE study, the very first randomized trial conducted to determine how to improve the prognosis of tricuspid regurgitation.

To do so, the study aimed at comparing optimal medical treatment with interventions with edge-to-edge repair.

The content...

Implications of TRILUMINATE, a randomized clinical trial of transcatheter repair for tricuspid regurgitation

What is the best contemporary interventional management of out-of-hospital cardiac arrest?

17 May 2023 – From EuroPCR 2023

Thomas Keeble and Marko Noc tackle the tricky question of how to deal with a patient with out-of-hospital cardiac arrest.

While STEMI patients should almost invariably go directly to the cathlab, the situation seems less clear-cut for non-ST-elevation patients, for whom a genuinely personalized approach needs to be proposed.

Study...

What is the best contemporary interventional management of out-of-hospital cardiac arrest?

What are the essential skillsets for aspiring transcatheter edge-to-edge mitral valve repair operators?

17 May 2023 – From EuroPCR 2023

Rebecca Hahn, interventional echocardiographer, and Sam Dawkins, interventional cardiologist, look at the skills a good fellow needs to become an excellent interventional cardiologist, particularly in relation to mitral interventions.

Mastery of imaging and the three-dimensional nature of the heart seems to be the key to success, but...

What are the essential skillsets for aspiring transcatheter edge-to-edge mitral valve repair operators?

When to use drug coated balloons in de novo lesions?

What areas are most subject to drug-coated balloon angioplasty in de novo lesions? Fernando Alfonso and Robert Byrne provide some answers in this interview, in which they list the scenarios in which this technology appears attractive.

Small vessel disease, diffuse disease, STEMI, side-branches and patients at high-bleeding risk are...

When to use drug coated balloons in de novo lesions?

When should we perform PCI for stable coronary artery disease in aortic stenosis, pre, post, never?

17 May 2023 – From EuroPCR 2023

What is the evidence for the need for PCI in patients with stable coronary artery disease and severe aortic stenosis? Is invasive angiography always mandatory for these patients? What about CT scans? When exactly should PCI be performed?

These are the questions Vijay Kunadian and Martine Gilard...

When should we perform PCI for stable coronary artery disease in aortic stenosis, pre, post, never?

What is the role of intra-coronary physiology in guiding complete revascularisation?

17 May 2023 – From EuroPCR 2023

Nicola Ryan and Roberto Diletti discuss strategies for complete revascularisation in patients with acute coronary syndrome, and more specifically patients presenting with STEMI and multivessel disease.

What impact does physiology have on the completeness of revascularisation? Should complete revascularisation be guided by physiology? How does it improve performance? In...

What is the role of intra-coronary physiology in guiding complete revascularisation?

Pregnant women working in the cathlab

17 May 2023 – From EuroPCR 2023

Lynn Hinterbuchner welcomes Angeliki Kolyda, radiographer, in the PCR TV studio, in the heart of EuroPCR 2023, to talk about pregnancy in the cathlab. Should a woman really worry about working in a cathlab? If so, why? When exactly? How can she best protect herself?

Follow this...

Pregnant women working

What is the optimal aortic valve choice in the younger patient: transcatheter or surgery?

29 Nov 2023 – From PCR London Valves 2023

Follow the discussion between Darren Mylotte, Kentaro Hayashida and Ole De Backer to better understand the concept of "young patients" and what it exactly implies, and analyze how best to bring these specific patients to the end of their still potentially long life, by choosing the...

What is the optimal aortic valve choice in the younger patient: transcatheter or surgery?

Patient selection for tricuspid intervention - the role of the right heart

30 Nov 2023 – From PCR London Valves 2023

Interviewed by Jörg Hausleiter, Rebecca Hahn and Philipp Lurz provide insight into the right heart's role in tricuspid procedures.

How can we best assess right heart function in patients so as to choose the most appropriate therapy for them? How TTE and TEE can help? How can...

Patient selection for tricuspid intervention: the role of the right heart

How to prepare an excellent abstract for EuroPCR?

17 May 2023 – From EuroPCR 2023

Marjo De Ronde asks Davide Capodanno, Chief Editor of the EuroIntervention Journal, to describe the main steps for nurses, allied health professionals and researchers to get started with research.

If motivation and passion are the key words, the starting point remains the idea, which must be relevant, and...

How to prepare an excellent abstract for EuroPCR?

What is the role of intra-coronary physiology and imaging to guide left main bifurcation PCI?

17 May 2023 – From EuroPCR 2023

As Alejandro Travieso explains, physiology and imaging are complementary to achieve good assessment of left main PCI. Dejan Milasinovic adds that different imaging tools can be used in different patients, so practitioners may choose between OCT and IVUS, depending on their main target of interest.

Find out the specifics...

What is the role of intra-coronary physiology and imaging to guide left main bifurcation PCI?

What does lifetime management mean for the valve patient?

10 Jan 2024 – From PCR London Valves 2023

Bettina Kirk, Alexandra Baer and John Webb discuss the question of lifetime management for valve disease patients, and begin by outlining the main difficulties involved, offering both an interventional cardiologist's and a nurse's perspective.

Then, they are considering how this lifetime management could be improved in the...

The remaining big questions in transcatheter tricuspid valve intervention - PCR London Valves 2023

Results from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast reduction) Trial

16 May 2023 – From EuroPCR 2023

Javier Escaned joins Ajay Kirtane to discuss the DCR4C Trial he conducted, and more specifically to present the main results.

The framework of the study was the contrast reduction during PCI, which is closely related to what is now known as ultra-low contrast PCI, and which mainly concerns particularly...

Results from the DCR4Contrast

The CorFlow MOCA I Trial: learnings from the first-in-human direct measurement of microvascular obstruction in STEMI

16 May 2023 – From EuroPCR 2023

To help you better understand the MOCA I Late-Breaking clinical Trial and its findings, follow this exchange between Rob Schwartz, Marco Valgimigli, and Azeem Latib.

What is this study about? What technology are we talking about exactly? Why is it important for clinical practice? How can we...

The CorFlow MOCA I Trial:

New developments in intravascular lithotripsy after 5 years of clinical practice

17 May 2023 – From EuroPCR 2023

Angela McInerney and James Spratt look back at 5 years of intravascular lithotripsy and how it has evolved from its beginnings to the present day.  

Calcium has always been a very complex issue especially in older patients, but the tools to treat it were somewhat limited....

New developments in intravascular

The remaining big questions in transcatheter tricuspid valve intervention

18 Dec 2023 – From PCR London Valves 2023

Rebecca Hahn, Anita Asgar and Scott Lim discuss where management and treatment of tricuspid valve diseases stand today.

Even if the subject has finally found its place, a number of questions remain unanswered and deserve to be addressed: Who are the patients that should be treated with...

The remaining big questions in transcatheter tricuspid valve intervention - PCR London Valves 2023
Didn’t find what you were looking for?